Lenders One Reports Strong Sales Momentum in Origination Solutions Estimated $15 Million in Annual Closed-Won Contracts and Expanding Late-Stage Pipeline with over 39 Prospects LUXEMBOURG, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource®” or the “Company”) (NASDAQ: ASPS), a leading provider of real estate and mortgage solutions, today announced significant sales momentum in its Origination Solutions business, driven by strong demand for Lenders One® Credit (“L1 Credit”) and Lenders One® Verification (“L1 Verification”) services. The Company recently si...
A director at First Interstate Bancsystem Inc sold 30,432 shares at 31.030USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
n this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update 3Q 2025 Total Revenue of $134.2 Million, a 12% YoY Increase 3Q 2025 GAAP Net Income of $36.4 Million, a 1% YoY Increase 3Q 2025 Adjusted EBITDA(1) of $58.7 Million, a 29% YoY Increase 3Q 2025 Adjusted Net Income(2) of $38.9 Million, an 8% YoY Increase FDA Lot Release of First Yield-Enhanced Production Batches Positions ADMA for Margin Expansion Beginning in 4Q 2025 and Continuing Through 2026 Positive, Statistically Significant Real-World Health Outcomes Demonstrated for ASCENIV™ Record ASCE...
ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025 Conference Call Scheduled for November 5, 2025, at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, today announced that it will report third quarter 2025 financial results on November 5, 2025, after the U.S. financial markets close. ADMA’s management team will host a live confe...
Altisource Announces Form S-3 Filing Related to Shares Previously Issued to Lenders LUXEMBOURG, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, filed a Form S-3 Registration Statement with the Securities and Exchange Commission on October 24, 2025 related to the registration of the resale of the shares previously issued to its lenders under the Securities Act of 1933, as amended (the “Form S-3”). On February 19, 2025, Altisource entered int...
Altisource Announces Third Quarter 2025 Financial Results LUXEMBOURG, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today reported financial results for the third quarter 2025. “We delivered solid third quarter performance. We grew Service revenue and improved pre-and post-tax GAAP earnings, GAAP earnings per share, and cash flow from operations compared to the third quarter of last year. This is largely from our focus on growing our busi...
Altisource Portfolio Solutions S.A. Schedules Third Quarter 2025 Conference Call LUXEMBOURG, Oct. 20, 2025 (GLOBE NEWSWIRE) -- On Thursday, October 23, 2025, Altisource Portfolio Solutions S.A. (“Altisource”) (NASDAQ: ASPS) will report earnings for the third quarter 2025. A press release and presentation will be available on Altisource’s website in the Investor Relations section. Altisource will also host a conference call at 8:30 a.m. EDT on the same day to discuss its third quarter 2025 results. A link to the live audio webcast will be available on Altisource’s website in the Investor...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Equator Expands Customer Network with Leading Real Estate and Mortgage Companies Leading firms choose Equator to leverage advanced automation and customizable workflows for more efficient property lifecycle management LUXEMBOURG, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Equator®, an Altisource® (NASDAQ: ASPS) business and a leading SaaS platform for real estate transaction management, today announced the addition of four prominent organizations to its growing list of customers, including Renovo Financial (RF Mortgage Services Corporation) and HGF Management. These companies join a robust netw...
ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update 2Q 2025 Total Revenue of $122.0 Million, a 14% YoY Increase, and a 29% YoY Increase Excluding a Prior Year Non-Recurring Item 2Q 2025 GAAP Net Income of $34.2 Million, a 7% YoY Increase 2Q 2025 Adjusted EBITDA(1) of $50.8 Million, a 59% YoY Increase Excluding a Prior-Year Non-Recurring Item 2Q 2025 Adjusted Net Income(2) of $36.0 Million, an 85% YoY Increase Excluding a Prior-Year Non-Recurring Item Initiated Commercial-Scale Manufacturing with FDA-Approved Yield Enhancement Process; Initial Ba...
ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025 Conference Call Scheduled for August 6, 2025, at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced that it will report second quarter 2025 financial results on August 6, 2025, after the U.S. financial markets close. ADMA’s management team will host a live conferen...
Altisource Announces Second Quarter 2025 Financial Results LUXEMBOURG, July 24, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today reported financial results for the second quarter 2025. “We are pleased with our second quarter performance. In a close to historically low delinquency environment, we grew Service revenue, Adjusted EBITDA(1), pre- and post-tax GAAP earnings and GAAP earnings per share compared to the second quarter of last year. This...
Altisource Portfolio Solutions S.A. Schedules Second Quarter 2025 Conference Call LUXEMBOURG, July 21, 2025 (GLOBE NEWSWIRE) -- On Thursday, July 24, 2025, Altisource Portfolio Solutions S.A. (“Altisource”) (NASDAQ: ASPS) will report earnings for the second quarter 2025. A press release and presentation will be available on Altisource’s website in the Investor Relations section. Altisource will also host a conference call at 8:30 a.m. EDT on the same day to discuss its second quarter 2025 results. A link to the live audio webcast will be available on Altisource’s website in the Investor ...
Effect of Altisource 1-for-8 Share Consolidation on Publicly Traded Warrants LUXEMBOURG, June 03, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today announced that the effects of the recent consolidation of its shares of common stock (also known as a reverse stock split) at a ratio of 1-for-8 (the “Share Consolidation”) on its publicly traded warrants. As previously disclosed, the Share Consolidation became effective as of 12:01 a.m. CET on May 28...
Altisource Shares to Be Consolidated at a Ratio of 1-for-8 Action Expected to Allow the Company to Regain Compliance with Nasdaq Minimum Bid Price Requirement LUXEMBOURG, May 23, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today announced that it will effect a consolidation of its shares (also known as a reverse stock split) at a ratio of 1-for-8, effective as of 12:01 a.m. CET on May 28, 2025 (the “Share Consolidation”). Altisource’s common s...
Altisource Announces Shareholder Approval of Reverse Stock Split and Treatment of Fractional Shares Shareholders Must Hold Shares in Multiples of Eight by Market Close on May 27, 2025 to Avoid Fractional Share Cash-Out LUXEMBOURG, May 13, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today announced that its shareholders have overwhelmingly approved a reverse stock split (the “Share Consolidation”) at the Company’s Extraordinary General Meeting of...
ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update 1Q 2025 Total Revenue of $114.8 Million (Adjusted Total Revenue(1) of $118.6 Million), a 40% YoY Increase 1Q 2025 GAAP Net Income of $26.9 Million, a 51% YoY Increase 1Q 2025 Adjusted EBITDA(2) of $47.9 Million, an 81% YoY Increase 1Q 2025 Adjusted Net Income(3) of $33.3 Million, an 87% YoY Increase 1Q 2025 Total Cash and Receivables Grew to Approximately $171 Million FDA Approved Yield Enhancement Process Anticipated to Provide 20% Production Output Enhancement from Same Starting Plasma Volume...
Altisource Announces Listing of Warrants on Nasdaq Global Select Market with Trading to Commence on May 7, 2025 Cash Exercise Stakeholder Warrants to Trade on the Nasdaq Global Select Market Under the Ticker “ASPSZ” Net Settle Stakeholder Warrants to Trade on the Nasdaq Global Select Market Under the Ticker “ASPSW” LUXEMBOURG, May 06, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today announced that the Warrants (defined below) that were distrib...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.